StockData
Harvard Apparatus Regenerative Technology, Inc. logo

Harvard Apparatus Regenerative Technology, Inc. (HRGN) stock

HRGNOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$2.21−0.02 (-0.72%)

Close on Oct 19, 2026Market cap $40.13MP/E –Yield –

Harvard Apparatus Regenerative Technology enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Harvard Apparatus Regenerative Technology's enterprise value was $38.57M on Oct 19, 2026, against $29.94M a year earlier. Over the last 5 years it ranged from $17.86M to $81.21M, with a median of $43.15M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$38.57M+27.4%
2025Dec 31, 2025$30.27M-30.9%
2024Dec 31, 2024$43.84M-35.3%
2023Dec 29, 2023$67.77M+11.3%
2022Dec 30, 2022$60.92M+170.3%
2021Dec 31, 2021$22.54M+129.6%
2020Dec 31, 2020$9.82M-30.9%
2019Dec 31, 2019$14.22M-99.9%
2018Dec 31, 2018$11.67B+2774407.9%
2017Dec 29, 2017$420.76K-95.4%
2016Dec 30, 2016$9.22M-52.4%
2015Dec 31, 2015$19.38M+12.3%
2014Dec 31, 2014$17.26M–

More Harvard Apparatus Regenerative Technology figures

See a number that looks wrong?